Sales & Marketing Sponsored Beyond the launch date: Why pharma must rethink readiness fo... Explore why pharma companies must rethink their NHS strategies post-launch, with tools like IQVIA'S Market Access Launch Pad.
Sales & Marketing What can FDA really do about DTC pharma advertising? What legal hurdles does the FDA face in changing the rules for broadcast advertising? And what should the industry be doing to prepare for changes?
Sales & Marketing People, leadership, and change efforts: A Q&A with Mark Gree... A new Q&A seeks to provide insights on how to build change programmes that actually work – from clinical teams to board level.
Sales & Marketing Sponsored Solution Spotlight: IQVIA Market Access Launch Pad IQVIA Market Access Launch Pad is a dynamic and comprehensive suite of tools designed to support pharmaceutical companies in their product launch readiness.
Sales & Marketing FH25: Individual centric investing with Steve Seuntjens In a new FH25 podcast episode, Deep Dive editor Eloise McLennan speaks with Steve Seuntjens, Partner at PHS Capital.
Sales & Marketing Pharma and health advertising: Brian Coane on the necessity ... Brian Coane, health partner at Leith, talks sensitivity, maximum impact, and overcoming the fear of getting humour in pharma advertising wrong.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.